Clinical Trials Logo

Anorexia Nervosa clinical trials

View clinical trials related to Anorexia Nervosa.

Filter by:

NCT ID: NCT02458950 Completed - Anorexia Nervosa Clinical Trials

Characteristics and Clinical Outcomes of Anorexia Nervosa : Siriraj Hospital Experience

Start date: December 2014
Phase:
Study type: Observational

This study is aimed to determine clinical characteristics of patients with anorexia nervosa and outcome of treatment at Sirirraj Hospital.

NCT ID: NCT02400541 Completed - Anorexia Nervosa Clinical Trials

Efficacity of Cognitive Remediation Treatment Compared to a Controlled Group in Young Patient With Anorexia Nervosa

RECOGAMEA
Start date: March 2015
Phase: N/A
Study type: Interventional

The aim of research is to test in a randomized clinical trial with active sessions, the efficacy of cognitive remediation therapy in children anorexia nervosa compared to a controlled group. The investigators want to confirm the efficacy of cognitive remediation treatment in children's flexibility problems.

NCT ID: NCT02382497 Recruiting - Anorexia Nervosa Clinical Trials

New Treatment Perspectives in Eating Disorders: the Efficacy of Non-invasive Brain-directed Treatment

Start date: July 2014
Phase: N/A
Study type: Interventional

The present study grounds on the possible role of hemispheric lateralization in Eating disorders (ED): specifically, hyperactivity of the right frontal regions in Anorexia Nervosa (AN), and hypoactivity of the right frontal regions in Binge Eating Disorder (BED) and food craving behaviors. Therefore, the investigators hypothesized that active excitatory tDCS over left prefrontal cortex (PFC) (Anode left/cathode right) may aid in altering/resetting inter-hemispheric balance in AN patients, re-establish control over eating behaviors. On the contrary, active excitatory tDCS over right PFC (Anode right/cathode left) may aid in altering/resetting inter-hemispheric balance in BED patients and people with frequent food cravings, decreasing cravings/appetite binge eating behaviors.

NCT ID: NCT02382055 Completed - Anorexia Nervosa Clinical Trials

Changing Habits in Anorexia Nervosa: Novel Treatment Development

REACH
Start date: September 2015
Phase: N/A
Study type: Interventional

The investigators are examining what types of psychotherapy are most helpful for patients as they undergo weight restoration treatment for anorexia nervosa. In this study, patients who are receiving care on our inpatient unit will also receive 4 weeks of one two types of psychotherapy: Supportive Psychotherapy or Regulation Emotions and Changing Habits.

NCT ID: NCT02381639 Completed - Anorexia Nervosa Clinical Trials

Impairment of Central Coherence in Restrictive Anorexia Nervosa (CoCA)

CoCA
Start date: June 11, 2015
Phase: N/A
Study type: Interventional

The current etiological pathological model of anorexia nervosa is poly-factorial involving individual genetic and psychological factors, in close interaction with environmental, family and socio-cultural factors. Among these factors, this study focuses on the central coherence process (cognitive ability to integrate complex information into a comprehensive meaning), in the active phase of the disease. Therefore, patients followed in the addiction service of the Nantes University Hospital will perform neuropsychological tests assessing executive functions involved in the process of central coherence. Impairment of central coherence process could act as a maintenance factor of the disease, particularly in connection with body dysmorphic disorder. The therapeutic perspectives acting on the central coherence process like cognitive remediation deserve to deepen knowledge on the cognitive profile of patients with anorexia nervosa.

NCT ID: NCT02359123 Completed - Cancer Cachexia Clinical Trials

Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients

Start date: November 2016
Phase: N/A
Study type: Interventional

The main purpose in the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS) is to prolong life and to improve quality of life (QoL) as far as possible. QoL in patients with CACS is directly related to loss of appetite and loss of weight. Cannabis pills are given in Israel to advanced cancer patients with various symptoms in order to improve their QoL. There is data on safety/toxicity of cannabis, and these pills are given under the regulations of the Israel Ministry of Health. The purpose of this study is to examine the influence of Cannabics capsules on improving loss of appetite and loss of weight.

NCT ID: NCT02336841 Not yet recruiting - Anorexia Nervosa Clinical Trials

Self-Help And Recovery Guide in Eating Disorders

SHARED
Start date: January 2015
Phase: Phase 0
Study type: Interventional

The aim of this study is to test a novel guided self-help intervention for patients with Anorexia Nervosa. The 6-week intervention includes the use of self-help materials (i.e. a workbook and short video-clips) and weekly guidance from a peer mentor (i.e. a person recovered from Anorexia Nervosa). Self-reports will be completed at baseline, end of 6 weeks, and 6- and 12 months follow-up. Participants interested in taking part will be randomly allocated to one of two groups.

NCT ID: NCT02333500 Completed - Anorexia Clinical Trials

Oxytocin and Incitement to Use Olfactory Stimuli in Restrictive Anorexia Nervosa

Start date: February 11, 2015
Phase: N/A
Study type: Interventional

This prospective pilot study will compare adolescents with restrictive anorexia nervosa who participated for 3 months at olfactory workshops, patients who did not, and healthy patients.The groups will be evaluated before the workshops and after three months, with the wanting score after olfactory stimuli and with serum oxytocin level.

NCT ID: NCT02263404 Not yet recruiting - Anorexia Nervosa Clinical Trials

PINS Stimulator System to Treat Severe Anorexia Nervosa

Start date: December 2016
Phase: Phase 0
Study type: Interventional

Anorexia Nervosa (AN) has the highest mortality of any psychiatric disorder and a paucity of effective treatments. AN becomes intractable in around 20%, resulting in huge individual and healthcare costs. The study will help patients with severe AN using DBS. Individuals with severe intractable AN will be eligible to take part in the study.

NCT ID: NCT02240797 Terminated - Anorexia Nervosa Clinical Trials

Kappa Opioid Receptor Imaging in Anorexia

Start date: September 2014
Phase: N/A
Study type: Observational

The purpose of this study is to use positron emission tomography (PET) imaging and magnetic resonance imaging (MRI) to understand the brain function of individuals with anorexia nervosa and healthy controls.